Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
Vasodilatory prostaglandins function to maintain renal perfusion in patients with cirrhosis and ascites. To evaluate the potential contribution of the vasodilator prostaglandin E2 and the vasoconstrictor metabolite thromboxane B2 to the development of the hepatorenal syndrome, we measured urinary excretion of these products in 14 patients with hepatorenal syndrome and in control populations with acute or chronic liver or kidney failure. Radioimmunoassay measurements were confirmed by bioassay and by mass spectrometry. Prostaglandin E2 was decreased compared with healthy controls (2.2 +/- 0.3 vs. 6.3 +/- 0.8 ng/h, p less than 0.01) and compared with acute renal failure (9.6 +/- 2.1 ng/h) and with alcoholic hepatitis (9.2 +/- 3.3 ng/h). Thromboxane B2 concentration was normal in patients with alcoholic hepatitis (0.12 +/- 0.02 vs. 0.15 +/- 0.03 ng/ml) and minimally increased in acute renal failure (0.18 +/- 0.15 ng/ml), but markedly elevated in hepatorenal syndrome (0.69 +/- 0.15 ng/ml, p less than 0.001). Urinary thromboxane B2 concentration fell with improved renal function in 3 patients who survived. These data suggest an imbalance of vasodilator and vasoconstrictor metabolites of arachidonic acid in patients with the hepatorenal syndrome.
D000208:Acute Disease; D058186:Acute Kidney Injury / Q000652:urine; D000293:Adolescent; D000328:Adult; D001681:Biological Assay; D002908:Chronic Disease; D015232:Dinoprostone; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000652:urine*; D007676:Kidney Failure, Chronic / Q000652:urine; D008107:Liver Diseases / Q000652:urine*; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D011458:Prostaglandins E / Q000652:urine*; D011863:Radioimmunoassay; D013577:Syndrome; D013929:Thromboxane B2 / Q000652:urine*; D013931:Thromboxanes / Q000652:urine*
D011458:Prostaglandins E; D013931:Thromboxanes; D013929:Thromboxane B2; D015232:Dinoprostone